Vivalink
↗Campbell, USA
Vivalink is a provider of digital healthcare solutions for virtual care and decentralized clinical trials. The company leverages physiology-optimized medical wearable sensors and data services to enable a deeper clinical understanding between providers and patients.
Their core offering is a Biometrics Data Platform that includes a variety of medical-grade sensors (ECG, SpO2, BP, Temperature) and an IoT infrastructure designed for rapid deployment in hospital-at-home and clinical research settings. The technology is used by over 300 customers across 50+ countries.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:
Industry:Digital Health
Sub-Industry:Medical Devices / Remote Patient Monitoring
SIZE & FINANCIALS
Employees:51-200
Revenue:$10M-$25M (estimate)
Founded:2014
Ownership:private
Status:operating
FUNDING
Stage:Series B
Total Raised:$8.5M
Investors:Niterra, Pegasus Tech Ventures, HHS
PIPELINE
Stage:Commercial
Lead Drug Stage:FDA Cleared / CE Marked
Modalities:Wearable Sensors, IoT Platform, AI Algorithms
Active Trials:20
Trial Phases:Phase 1: 5 | Phase 2: 8 | Phase 3: 7
FDA Approvals:5
EMA Approvals:3
CORPORATE STRUCTURE
Subsidiaries:Vivalink China
Key Partnerships:Niterra (Strategic Investment), Reckitt Benckiser, Microsoft (Research)
COMPETITION
Position:Leader
Competitors:BioIntelliSense, iRhythm Technologies, VitalConnect, BardyDx
LEADERSHIP
Key Executives:
Jiang Li - CEO
Aaron Timm - CCO
Scientific Founders:Niel Starksen
Board Members:Jennifer Esposito, Niel Starksen
LINKS
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Vivalink and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Vivalink. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.